This damage disrupts the normal flow of electrical signals between the brain and body, leading to a wide range of symptoms, including fatigue, mobility problems, vision issues, numbness, and cognitive changes
While they work in slightly different ways, they all belong to the same class of medications that target the bodys hormonal pathways to support weight loss
What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Data source: Multiple peer-reviewed studies published 2025-2026, including British Journal of Pharmacology, Nature Reviews Endocrinology, and body composition literature on STEP and SURMOUNT trial data Key finding: Up to 40% of weight lost on high-efficacy GLP-1 drugs is lean body mass
Choose Your Injection Site: Semaglutide is a subcutaneous injection, meaning it goes just under the skin into the fatty layer
Its also important to understand how these changes affect which medications patients receive at the pharmacy, and weve released a companion report that uses dispense data to examine switching patterns
